News | January 03, 2024
WuXi XDC partners with IntoCell to accelerate ADC discovery and development
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Sirius JV will be owned 51% by Sirius and 49% by Adani
NEIAFMR to be developed as the national hub for folk medicine
The product is expected to be launched in December 2023
World HRD Congress is a well-known international body of Management Studies
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
Express Scripts to add Zepbound to National Preferred Formulary
Both the India and GCC entities will be operated by separate dedicated management teams
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Subscribe To Our Newsletter & Stay Updated
